Bimodal distribution ofCandida albicansin children with Autism linked with ASD symptoms

Abstract

The gastrointestinal (GI) tract harbors an intricate and remarkably diverse microbial ecosystem that profoundly impacts various aspects of health and pathophysiology. While bacteria overwhelmingly represent most of the GI microbiota, it is imperative to consider the presence and function of fungal constituents (i.e., mycobiota) within the GI ecosystem. The substantial incidence of GI disorders and associated manifestations in children diagnosed with autism spectrum disorder (ASD) suggests a plausible contributory role of the gut mycobiota. Our investigation aimed to elucidate the gut mycobiota in a cohort comprising 38 typically developing children (TD) and 40 children with ASD. Fecal samples were collected from all participants and autism severity and GI symptoms were assessed to unravel the potential implications of mycobiota alterations in the gut. We employed fungal internal transcribed spacer (ITS) gene amplicon sequencing to analyze the fungal composition and investigate their relationship with GI and autism symptoms. Among gut mycobiota, Saccharomyces cerevisiae was significantly lower (relative abundance) in ASD compared to TD children. Total Candida and C. albicans demonstrated a bimodal distribution among children with ASD. Children with ASD with elevated Autism Treatment Evaluation Checklist (ATEC) scores (a more severe diagnosis) displayed an increased abundance of C. albicans and a decreased abundance of S. cerevisiae. A significant positive correlation was observed between ATEC scores and GI symptoms and between ATEC scores and C. albicans. Our findings propose that a deficit of beneficial fungi, specifically S. cerevisiae, and an overgrowth of C. albicans may worsen autism severity in children with ASD. Future work employing more advanced techniques (i.e., shotgun metagenomics) is encouraged to advance understanding of the functional role of fungi/yeast, and their interplay between GI symptoms and autism severity in children with ASD.

Gut microbiota functional profiling in autism spectrum disorders: bacterial VOCs and related metabolic pathways acting as disease biomarkers and predictors

“…Particularly, most patients affected by ASD, generally males ( Loomes et al, 2017 ), show GI morbidities ( Mottron and Bzdok, 2020 ), often associated with impaired digestion of carbohydrates and gut dysbiosis ( Williams et al, 2011 ), hence altered gut microbiota (GM) composition and metabolism may play a crucial role in ASD phenotypes and comorbidities ( De Angelis et al, 2015 ; Vernocchi et al, 2022 ). GM microbial profiles ( Shoubridge et al, 2022 ) have been thoroughly investigated in terms of gut microbial ecology in ASD children compared with neurotypical children ( De Angelis et al, 2015 ; Adams et al, 2022 ; Nirmalkar et al, 2022 , 2023 ; Phan et al, 2022 ; Taniya et al, 2022 ; Vernocchi et al, 2022 ). However, through the “gut-brain axis,” gut microbial-driven metabolites ( Järbrink-Sehgal and Andreasson, 2020 ) may exert crucial effects on the physiology of the central nervous system (CNS) and association to ASD ( Thomas et al, 2012 ; MacFabe, 2015 ).…”